Learn About TB Infection and Prevention

Understanding TB Infection: What You Need to Know

Tuberculosis, commonly called TB, is an infectious disease caused by bacteria called Mycobacterium tuberculosis. This disease primarily affects the lungs, though it can spread to other parts of the body including the kidneys, spine, and brain. According to the World Health Organization, TB remains one of the top infectious disease killers globally, with approximately 10 million people developing active TB disease each year. Understanding how TB spreads and develops is the first step toward protecting yourself and others in your community.

TB spreads through the air when an infected person coughs, sneezes, speaks, or sings. The bacteria travel in tiny droplets that can remain suspended in the air for several hours. Unlike many contagious illnesses, TB does not spread through touching, sharing food or drinks, or shaking hands. A single exposure to TB bacteria does not automatically mean someone will become sick. Many factors influence whether infection develops, including the strength of your immune system, the duration of exposure, and the bacterial load in the air.

It is important to recognize that TB infection differs from TB disease. TB infection means TB bacteria are in your body but your immune system is controlling them. You may not feel sick and cannot spread TB to others. TB disease occurs when the bacteria multiply and cause illness. This distinction matters because someone with TB infection may never develop TB disease, while others progress within weeks or months. Approximately 5-10% of people with TB infection will develop TB disease at some point in their lives.

Common symptoms of TB disease include a persistent cough lasting three weeks or longer, chest pain when breathing or coughing, coughing up blood or mucus, fever, chills, and night sweats. Fatigue and weight loss also frequently occur. These symptoms may develop gradually over weeks, which is why TB is sometimes called a "slow" disease. If someone experiences these symptoms for more than three weeks, they should contact a healthcare provider for evaluation.

Practical takeaway: Learn to recognize TB symptoms in yourself and others. If you or someone you know has a cough lasting more than three weeks, fever, or unexplained weight loss, seek medical evaluation. This helps catch TB early when treatment is most effective.

Who Is at Higher Risk for TB Infection and Disease

Certain populations face higher risk of TB infection and disease development. Healthcare workers, people who work in prisons or homeless shelters, and those living in crowded conditions have increased exposure risk. Close contacts of people with active TB disease—including family members, coworkers, or classmates—also face higher transmission risk. Understanding your personal risk factors can help guide decisions about testing and prevention.

People with weakened immune systems are at significantly higher risk of developing TB disease once infected. This includes individuals with HIV/AIDS, those taking medications that suppress immune function, people with diabetes, and those with kidney disease. According to the Centers for Disease Control and Prevention, a person with untreated HIV is approximately 20-30 times more likely to develop active TB disease than someone with a healthy immune system. Malnutrition and substance use disorders also weaken immune response and increase TB disease risk.

Certain medical conditions increase TB disease risk. These include chronic lung disease, heart disease, cancer, and conditions requiring immunosuppressive medications. Children under five years old who are infected with TB bacteria have higher rates of progression to TB disease. Older adults also show increased susceptibility, partly because immune function naturally declines with age. People born in or with family connections to countries with high TB rates carry different risk profiles than those in low-incidence areas.

Social and economic factors significantly influence TB risk. Crowded living conditions, poverty, lack of access to healthcare, and food insecurity all contribute to higher TB rates. Incarcerated individuals face substantially elevated risk due to confined spaces and limited access to medical care. Migrant workers, people experiencing homelessness, and those in underserved communities encounter both higher exposure and greater barriers to diagnosis and treatment.

Practical takeaway: Assess your personal risk factors by considering your health status, occupation, living situation, and healthcare access. If you identify risk factors, discuss TB testing with a healthcare provider. Early identification of TB infection allows for preventive treatment before disease develops.

TB Testing and Diagnosis Explained

Two main types of TB tests exist: the tuberculin skin test (TST) and blood tests for TB infection. The TST, also called the Mantoux test, involves injecting a small amount of purified protein derivative (PPD) under the skin. A healthcare provider then examines the injection site 48-72 hours later to measure any reaction. A raised bump at the site indicates possible TB infection, though further testing is needed to confirm TB disease. The TST has been used for over a century and remains widely available.

Blood tests for TB, called interferon-gamma release assays (IGRAs), measure immune system response to TB antigens. These tests require a single blood draw and provide results within 24 hours in many cases. IGRAs offer several advantages: they require only one visit, are not affected by prior BCG vaccination, and show good accuracy. Both TST and IGRA tests can indicate TB infection but cannot distinguish between TB infection and TB disease alone.

Confirming TB disease requires additional testing. Chest X-rays show characteristic patterns of TB in the lungs. Sputum samples (mucus coughed up from the lungs) are examined under microscopes for TB bacteria and cultured to grow the bacteria. Culture remains the gold standard for TB diagnosis and allows testing for drug resistance. Some facilities use rapid molecular tests like GeneXpert MTB/RIF, which can detect TB bacteria and rifampicin resistance within two hours. These tests are particularly valuable in settings with high TB rates.

The diagnostic process typically involves a healthcare provider taking a detailed medical history, performing a physical examination, and ordering appropriate tests based on individual circumstances. People with TB infection but no TB disease symptoms may receive only testing and counseling. Those with TB disease symptoms undergo comprehensive testing to confirm diagnosis and determine treatment options. Diagnosis accuracy depends on proper sample collection, laboratory quality, and appropriate test interpretation.

Practical takeaway: If you believe you have TB symptoms or have been exposed to someone with active TB, contact a healthcare provider to discuss testing options. Understanding what tests measure helps you prepare for appointments and comprehend results. Neither TST nor IGRA results alone diagnose TB disease; additional evaluation is always needed.

Treatment for TB Infection and Disease

TB is curable with proper medication treatment. People diagnosed with TB disease typically receive combination antibiotic therapy lasting six months. The standard first-line regimen includes isoniazid, rifampicin, pyrazinamide, and ethambutol for the first two months, followed by isoniazid and rifampicin for four additional months. This combination approach prevents drug resistance and achieves cure rates exceeding 85% when patients complete the full course. Treatment must continue the entire six months even after symptoms disappear, because incomplete treatment allows bacteria to survive and develop resistance.

People with TB infection but no disease symptoms may receive preventive therapy to reduce the risk of developing TB disease. Options include isoniazid monotherapy for six to nine months, or shorter courses combining other medications. Preventive therapy can reduce TB disease risk by approximately 60-90%. The specific regimen depends on factors including TB resistance patterns in the individual's region, concurrent health conditions, and potential drug interactions. Regular monitoring during preventive therapy ensures safety and effectiveness.

Side effects from TB medications occur but are generally manageable. Common side effects include nausea, loss of appetite, and abdominal discomfort. Some medications can affect liver function, requiring periodic blood tests to monitor liver health. Rifampicin may interact with other medications, including hormonal contraceptives, blood thinners, and diabetes medications. Patients must inform healthcare providers about all medications and supplements they take. Most side effects diminish over time or can be addressed through medication adjustments.

Drug-resistant TB presents greater treatment challenges. Multi-drug resistant TB (MDR-TB) resists at least isoniazid and rifampicin, the two most potent first-line drugs. Extensively drug-resistant TB (XDR-TB) additionally resists newer medications. These resistant forms require longer treatment durations—often 20 months or more—and involve more medications with potentially greater side effects. Success rates for drug-resistant TB are lower, around 50-60% depending on resistance patterns and treatment access. Drug resistance develops when patients don't complete full treatment courses or when treatment regimens are inadequate.

Practical takeaway: If diagnosed with TB